2',3'-dideoxy-beta-5-fluorocytidine has been researched along with Infections, Hepadnaviridae in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Borel, C; Cheng, YC; Dannaoui, E; Hantz, O; Lin, TS; Liu, SH; Trépo, C; Zoulim, F | 1 |
1 other study(ies) available for 2',3'-dideoxy-beta-5-fluorocytidine and Infections, Hepadnaviridae
Article | Year |
---|---|
2',3'-dideoxy-beta-L-5-fluorocytidine inhibits duck hepatitis B virus reverse transcription and suppresses viral DNA synthesis in hepatocytes, both in vitro and in vivo.
Topics: Animals; Antiviral Agents; Blotting, Southern; Cells, Cultured; DNA Replication; DNA, Viral; Ducks; Female; Hepadnaviridae Infections; Hepatitis B Virus, Duck; Liver; Reverse Transcriptase Inhibitors; Time Factors; Virus Replication; Zalcitabine | 1996 |